Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine S Grasso

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Bioinformatics (Oxford, England)|September 26, 2013
Methods and challenges in timing chromosomal abnormalities within cancer samplesElizabeth Purdom, Christine Ho, Catherine S Grasso, et al.
Cancer Letters|December 12, 2022
PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltrationShengchen Su, Sungyong You, Yanping Wang, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Detection of somatic copy number alterations in cancer using targeted exome capture sequencingRobert J Lonigro, Catherine S Grasso, Dan R Robinson, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Molecular and Cellular Endocrinology|September 23, 2017
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilitiesHillary Stires, Mary M Heckler, Xiaoyong Fu, et al.
Prostate Cancer and Prostatic Diseases|February 20, 2020
Copy number alterations are associated with metastatic-lethal progression in prostate cancerXiaoyu Wang, Catherine S Grasso, Kristina M Jordahl, et al.
Sarcoma|June 23, 2020
Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic SarcomaNoah E Berlow, Catherine S Grasso, Michael J Quist, et al.
Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.
Journal of Proteome Research|May 6, 2006
Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotypeVenkateshwar G Keshamouni, George Michailidis, Catherine S Grasso, et al.
Cancer Discovery|February 7, 2013
Outlier kinase expression by RNA sequencing as targets for precision therapyVishal Kothari, Iris Wei, Sunita Shankar, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Bioinformatics (Oxford, England)|September 26, 2013
Methods and challenges in timing chromosomal abnormalities within cancer samplesElizabeth Purdom, Christine Ho, Catherine S Grasso, et al.
Cancer Letters|December 12, 2022
PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltrationShengchen Su, Sungyong You, Yanping Wang, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Detection of somatic copy number alterations in cancer using targeted exome capture sequencingRobert J Lonigro, Catherine S Grasso, Dan R Robinson, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Molecular and Cellular Endocrinology|September 23, 2017
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilitiesHillary Stires, Mary M Heckler, Xiaoyong Fu, et al.
Prostate Cancer and Prostatic Diseases|February 20, 2020
Copy number alterations are associated with metastatic-lethal progression in prostate cancerXiaoyu Wang, Catherine S Grasso, Kristina M Jordahl, et al.
Sarcoma|June 23, 2020
Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic SarcomaNoah E Berlow, Catherine S Grasso, Michael J Quist, et al.
Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.
Journal of Proteome Research|May 6, 2006
Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotypeVenkateshwar G Keshamouni, George Michailidis, Catherine S Grasso, et al.
Cancer Discovery|February 7, 2013
Outlier kinase expression by RNA sequencing as targets for precision therapyVishal Kothari, Iris Wei, Sunita Shankar, et al.
Pageof 4